IGFBP3 and colorectal carcinoma: Furthermore, we examined associations between the methylation status of individual markers and their combination with the clinicopathological features in these primary CRCs, and for the first time report that IGFBP3 hypermethylation is a promising diagnostic and predictive biomarker in CRC patients.